Neuropathology of Parkinson disease

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836

AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY

FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529

Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology

Zimprich, A. A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M. J., Lincoln, S., Kachergus, J. M., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,087

ASL expression in ALDH1A1+ neurons in the substantia nigra metabolically contributes to neurodegenerative phenotype

Lerner, S., Eilam, R., Adler, L. N., Baruteau, J., Kreiser, T., Tsoory, M., Brandis, A. S., Mehlman, T., Ryten, M., Botía, J. A., et al. (2021) · Human Genetics · doi:10.1007/s00439-021-02345-5 · Cited by 19

Curcumin as a privileged scaffold molecule for various biological targets in drug development

Mir, R. H., Mohi-ud-din, R., Mir, P. A., Shah, A. J., Banday, N., Sabreen, S., Maqbool, M., Jan, R., Shafi, N., & Masoodi, M. H. (2022) · Studies in natural products chemistry · doi:10.1016/b978-0-323-91097-2.00010-8 · Cited by 22

Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats

Gubinelli, F., Sarauskyte, L., Venuti, C., Kulacz, I., Cazzolla, G., Negrini, M., Anwer, D., Vecchio, I., Jakobs, F., Manfredsson, F. P., et al. (2022) · Current Research in Neurobiology · doi:10.1016/j.crneur.2022.100065 · Cited by 21

Lutein and the Underlying Neuroprotective Promise against Neurodegenerative Diseases

Iyer, S., Bhat, I., & Sheshappa, M. B. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300409 · Cited by 22

Performance-Driven Handwriting Task Selection for Parkinson’s Disease Classification

Angelillo, M. T., Impedovo, D., Pirlo, G., & Vessio, G. (2019) · Lecture notes in computer science · doi:10.1007/978-3-030-35166-3_20 · Cited by 21

Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single‐Photon Emission Computed Tomography Study

Palermo, G., Giannoni, S., Frosini, D., Morganti, R., Volterrani, D., Bonuccelli, U., Pavese, N., & Ceravolo, R. (2020) · Movement Disorders · doi:10.1002/mds.28008 · Cited by 21

Matrine exerts its neuroprotective effects by modulating multiple neuronal pathways

Chhabra, S., & Mehan, S. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01214-6 · Cited by 21

Transferrin-conjugated magnetic nanoparticles for the isolation of brain-derived blood exosomal MicroRNAs: A novel approach for Parkinson's disease diagnosis

Jang, Y. O., Roh, Y., Shin, W., Jo, S., Koo, B., Liu, H., Kim, M. G., Lee, H. J., Qiao, Z., Lee, E. Y., et al. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342623 · Cited by 21

Multiple molecular pathways stimulating macroautophagy protect from alpha-synuclein-induced toxicity in human neurons

Höllerhage, M., Fussi, N., Rösler, T. W., Wurst, W., Behrends, C., & Höglinger, G. U. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.023 · Cited by 19

Cardiovascular alterations in rats with Parkinsonism induced by 6-OHDA and treated with Domperidone

Rodrigues, L. D., Oliveira, L. F., Shinoda, L., Scorza, C. A., Faber, J., Ferraz, H. B., Britto, L. R., & Scorza, F. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-45518-z · Cited by 19

Detection and modulation of neurodegenerative processes using graphene-based nanomaterials: Nanoarchitectonics and applications

Tiwari, P., & Tiwari, S. (2022) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2022.102824 · Cited by 19

Formononetin Exerts Neuroprotection in Parkinson’s Disease via the Activation of the Nrf2 Signaling Pathway

Wang, X., Kang, N., Liu, Y. M., & Xu, G. (2024) · Molecules · doi:10.3390/molecules29225364 · Cited by 19

Non-Cell-Autonomous Neurotoxicity in Parkinson’s Disease Mediated by Astroglial α-Synuclein

Chai, M., & Kohyama, J. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.011 · Cited by 19

Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease

Heckman, M. G., Kasanuki, K., Brennan, R. R., Labbé, C., Vargas, E. R., Soto, A. I., Murray, M. E., Koga, S., Dickson, D. W., & Ross, O. A. (2019) · Movement Disorders · doi:10.1002/mds.27773 · Cited by 19

The value of PET/CT in the diagnosis and differential diagnosis of Parkinson’s disease: a dual-tracer study

Du, X., Zhao, H., Li, Y., Dai, Y., Gao, L., Li, Y., Fan, K., Sun, Z., & Zhang, Y. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00786-z · Cited by 18

Identification of Altered Blood MicroRNAs and Plasma Proteins in a Rat Model of Parkinson’s Disease

Yadav, S. K., Pandey, A. K., Sarkar, S., Yadav, S., Parmar, D., & Yadav, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02636-y · Cited by 18

Enhancement of Dopamine Electrochemical Detection with Manganese Doped Crystalline Copper Oxide

Gutoiu, S., Pogăcean, F., Mǎgeruşan, L., Miclaus, M. O., Grad, O. A., Pană, O., & Pruneanu, S. M. (2023) · Coatings · doi:10.3390/coatings13061014 · Cited by 18

Targeting mGluR group III for the treatment of neurodegenerative diseases

Rabeh, N., Hajjar, B. M., Maraka, J. O., Sammanasunathan, A. F., Khan, M., Alkhaaldi, S. M. I., Mansour, S., Almheiri, R. T., Hamdan, H., & Abd‐Elrahman, K. S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115733 · Cited by 18

Autophagy and UPS pathway contribute to nicotine-induced protection effect in Parkinson’s disease

Ullah, I., Shahab Uddin, M. S., Zhao, L., Wang, X., & Li, H. (2024) · Experimental Brain Research · doi:10.1007/s00221-023-06765-9 · Cited by 20

Comparative study between bone marrow mesenchymal stem cell and their conditioned medium in the treatment of rat model of Parkinsonism

Abdelwahab, S. A., Elsebay, S. A. G., Ibrahim, M. F. G., & Hafez, S. M. N. A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29872 · Cited by 18

Astrocytes in Parkinson's disease: from preclinical assays to in vivo imaging and therapeutic probes

Zeng, Z., Roussakis, A., Lao–Kaim, N. P., & Piccini, P. P. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.07.012 · Cited by 19

Variability of Voluntary Cough Airflow in Healthy Adults and Parkinson’s Disease

Borders, J. C., Brandimore, A. E., & Troche, M. S. (2020) · Dysphagia · doi:10.1007/s00455-020-10190-3 · Cited by 18

The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson’s Disease

Oh, Y.-S., Yoo, S.-W., Lyoo, C. H., Yoo, J.-Y., Yoon, H., Ha, S., Lee, K.-S., & Kim, J.-S. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202496 · Cited by 19

Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal—Intestinal Inflammation Activited and Intestinal Microbiota—Metabolic Disorders Induced in MPTP Mouse Model of Parkinson’s Disease

Liu, X., Liu, S., Tang, Y., Pu, Z., Xiao, H., Gao, J., Yin, Q., Jia, Y., & Bai, Q. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03293-2 · Cited by 18

Golgiphagy: a novel selective autophagy to the fore

Chen, Y., Wu, Y., Tian, X., Shao, G., Lin, Q., & Sun, A. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01311-8 · Cited by 18

Epigenetic Mechanisms Underlying Sex Differences in Neurodegenerative Diseases

Stoccoro, A. (2025) · Biology · doi:10.3390/biology14010098 · Cited by 18

Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab

Taylor, K. I., Lipsmeier, F., Scelsi, M. A., Volkova-Volkmar, E., Rukina, D., Popp, W., Lambrecht, S., Anzures‐Cabrera, J., Summers, D. M., Abt, M., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01572-8 · Cited by 17

Regulation of Mitochondrial Dynamics in Parkinson’s Disease—Is 2-Methoxyestradiol a Missing Piece?

Bastian, P., Dulski, J., Roszmann, A., Jacewicz, D., Kuban‐Jankowska, A., Sławek, J. W., Woźniak, M., & Górska‐Ponikowska, M. (2021) · Antioxidants · doi:10.3390/antiox10020248 · Cited by 17

Abnormally reduced frontal cortex activity during Trail-Making-Test in prodromal parkinson's disease–a fNIRS study

Hofmann, A., Rosenbaum, D., Int-Veen, I., Ehlis, A., Brockmann, K., Dehnen, K., von Thaler, A., Berg, D., Fallgatter, A. J., & Metzger, F. G. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.014 · Cited by 17

Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review

Oikonomou, P., & Jost, W. H. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02529-x · Cited by 17

Identification of Clec7a as the therapeutic target of rTMS in alleviating Parkinson's disease: targeting neuroinflammation

Chen, X., Feng, S., Bao, Y., Zhou, Y., & Ba, F. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166814 · Cited by 18

Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease

Ratan, Y., Rajput, A., Pareek, A., Pareek, A., Jain, V. K., Sonia, S., Farooqui, Z., Kaur, R., & Singh, G. (2024) · Biomolecules · doi:10.3390/biom14010073 · Cited by 18

Dyspnea in Parkinson’s disease: an approach to diagnosis and management

Vijayan, S., Singh, B., Ghosh, S., Stell, R., & Mastaglia, F. L. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1763795 · Cited by 17

The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy

Kakoty, V., Sarathlal, K. C., Dubey, S. K., Yang, C. H., Kesharwani, P., & Taliyan, R. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135865 · Cited by 18

L-Theanine Ameliorated Rotenone-Induced Parkinsonism-like Symptoms in Rats

Chen, C.-N., Wang, M., Soung, H.-S., Chen, S., Fang, C.-H., Lin, Y.-W., & Tseng, H.-C. (2022) · Neurotoxicity Research · doi:10.1007/s12640-021-00451-w · Cited by 17

Striatal GluN2B involved in motor skill learning and stimulus-response learning

Duan, Y., Wang, Q., Zeng, Q., Wang, J., Chen, Z., Xu, M., Duan, Y., Zhao, Z. Y., Xue, Q., & Cao, X. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.002 · Cited by 16

Diffusion–tensor MRI study of the relationship between glymphatic system asymmetry and onset lateralization in Parkinson’s disease

Li, Z., Miao, X., Zhang, Q., Shen, J., Jia, Y., Ge, S., Ji, P., Wang, J., Zhang, K., & Wang, M. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01074-0 · Cited by 18

LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson’s disease model

Blasco-Agell, L., Pons‐Espinal, M., Testa, V., Roch, G., Montero-Muñoz, J., Fernández‐Carasa, I., Baruffi, V., González-Sepúlveda, M., Richaud‐Patín, Y., Jiménez‐Delgado, S., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08544-4 · Cited by 16

Deciphering Electron-Shuttling Characteristics of Parkinson’s Disease Medicines via Bioenergy Extraction in Microbial Fuel Cells

Chen, B., Wu, Y.-C., Lin, Y.-H. T., Tayo, L. L., Tacas, A. C. J., & Hsueh, C. (2020) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.0c01062 · Cited by 16

α-Synuclein in Parkinson’s Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role?

Zheng, H., Shi, C., Luo, H., Fan, L., Yang, Z., Hu, X., Zhang, Z., Zhang, S., Hu, Z., Fan, Y., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420943180 · Cited by 21

Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis

Milanowski, Ł., Hou, X., Bredenberg, J. M., Fiesel, F. C., Cocker, L. T., Soto‐Beasley, A. I., Walton, R. L., Strongosky, A. J., Faroqi, A. H., Barcikowska, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137086 · Cited by 16

Transsulfuration pathway: a targeting neuromodulator in Parkinson’s disease

Corona-Trejo, A., Gonsebatt, M. E., Trejo‐Solís, C., Campos‐Peña, V., Granados, L. I. Q., Villegas‐Vázquez, E. Y., Reyes‐Hernández, O. D., Hernández-Abad, V. J., Figueroa‐González, G., & Silva‐Adaya, D. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2023-0039 · Cited by 17

Literature-Based Discovery Predicts Antihistamines Are a Promising Repurposed Adjuvant Therapy for Parkinson’s Disease

Tandra, G., Yoone, A., Mathew, R., Wang, M., Hales, C. M., & Mitchell, C. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512339 · Cited by 16

The neuroprotective effect of vitamin D in Parkinson's disease: association or causation

Hafiz, A. A. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2259680 · Cited by 16

Association between the risk and severity of Parkinson’s disease and plasma homocysteine, vitamin B12 and folate levels: a systematic review and meta-analysis

Quan, Y., Xu, J., Xu, Q., Guo, Z., Ou, R., Shang, H., & Wei, Q. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1254824 · Cited by 16

Spatial omics: An innovative frontier in aging research

Chen, Y., Yang, S., Yu, K., Zhang, J., Wu, M., Zheng, Y., Zhu, Y., Dai, J., Wang, C., Zhu, X., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102158 · Cited by 17

Opportunities and Pitfalls of REM Sleep Behavior Disorder and Olfactory Dysfunction as Early Markers in Parkinson’s Disease

Orso, B., Brosse, S., Frasnelli, J., & Arnaldi, D. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230348 · Cited by 16

Investigation of the genetic aetiology of Lewy body diseases with and without dementia

Wu, L., Real, R., Martínez-Carrasco, A., Chia, R., Lawton, M., Shoai, M., Bresner, C., Blauwendraat, C., Singleton, A., Ryten, M., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae190 · Cited by 18

Individual‐specific metabolic network based on 18F ‐ FDG PET revealing multi‐level aberrant metabolisms in Parkinson's disease

Lu, W., Song, T., Li, J., Zhang, Y., & Lu, J. (2024) · Human Brain Mapping · doi:10.1002/hbm.70026 · Cited by 16

Evaluation of Neuroprotective Effects of Polymeric Berberine Nanoparticles Against Parkinson’s Rat Model

Rayapudi, P., Kaur, J., & Naqvi, S. (2024) · BioNanoScience · doi:10.1007/s12668-024-01695-4 · Cited by 16

A Review of Biomarkers Use in Parkinson with Deep Brain Stimulation: A Successful Past Promising a Bright Future

Mugge, L., Krafcik, B. M., Pontasch, G., Alnemari, A. M., Neimat, J. S., & Gaudin, D. P. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.11.247 · Cited by 16

The Design and Application of an Appropriate Parkinson’s Disease Animal Model in Regenerative Medicine

Larijani, B. A., Goodarzi, P., Payab, M., Tayanloo-Beik, A., Sarvari, M., Gholami, M., Gilany, K., Nasli‐Esfahani, E., Yarahmadi, M., Ghaderi, F., et al. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_422 · Cited by 17

An in silico analysis of deleterious single nucleotide polymorphisms and molecular dynamics simulation of disease linked mutations in genes responsible for neurodegenerative disorder

Pandey, S., Dhusia, K., Katara, P., Singh, S., & Gautam, B. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1682047 · Cited by 16

Miro1 Impairment in a Parkinson’s At-Risk Cohort

Nguyen, D. T., Bharat, V., Lumbao-Conradson, K., Nandakishore, P., & Wang, X. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.734273 · Cited by 16

Influence of motor impairment on exercise capacity and quality of life in patients with Parkinson disease

Kanegusuku, H., Ritti‐Dias, R. M., Barbosa, P. Y. I., Guelfi, É. T. N., Okamoto, E., Miranda, C. S., Oliveira, T. D. P., & Piemonte, M. E. P. (2021) · Journal of Exercise Rehabilitation · doi:10.12965/jer.2142290.145 · Cited by 16

Metformin improves depressive-like behavior in experimental Parkinson’s disease by inducing autophagy in the substantia nigra and hippocampus

Mendonça, I. P., de Paiva, I. H. R., Duarte-Silva, E. P., de Melo, M. G., da Silva, R. S., do Nascimento, M. I. X., & Peixoto, C. A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01043-6 · Cited by 17

No Evidence of Increased Chronic Traumatic Encephalopathy Pathology or Neurodegenerative Proteinopathy in Former Military Service Members: A Preliminary Study

Tripathy, A., Shade, A., Erskine, B., Bailey, K., Grande, A. J., deLong, J. J., Perry, G. L., & Castellani, R. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181039 · Cited by 16

Alpha‐synuclein RT ‐ QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patients

Emmi, A., Mammana, A., Sandre, M., Baiardi, S., Weis, L., Rossi, M., Magliocchetti, F., Savarino, E. V., Russo, F. P., Porzionato, A., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52282 · Cited by 15

Activation of α7-nAChRs Promotes the Clearance of α-Synuclein and Protects Against Apoptotic Cell Death Induced by Exogenous α-Synuclein Fibrils

Zhao, J., Li, Y., Li, Y., Xu, S., Tao, T., Ye, H., Zhang, J., & Fan, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.637319 · Cited by 15

Acute effect of levodopa on orthostatic hypotension and its association with motor responsiveness in Parkinson's disease: Results of acute levodopa challenge test

Liu, Z., Su, D., Zhou, J., Wang, X., Wang, Z., Yang, Y., Ma, H., & Feng, T. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105860 · Cited by 15

The autophagy protein Atg9 functions in glia and contributes to parkinsonian symptoms in a Drosophila model of Parkinson’s disease

Yi, S., Wang, L., Ho, M. S., & Zhang, S. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382259 · Cited by 15

Analysis of Different Modality of Data to Diagnose Parkinson's Disease Using Machine Learning and Deep Learning Approaches: A Review

Arnab, S. B., Palash, M. I. A., Islam, R., Ovi, H. H., Yousuf, M. A., & Uddin, M. Z. (2024) · Expert Systems · doi:10.1111/exsy.13790 · Cited by 17

m6A Demethylase FTO -Mediated Upregulation of BAP1 Induces Neuronal Ferroptosis via the p53/SLC7A11 Axis in the MPP + /MPTP-Induced Parkinson’s Disease Model

Li, Z., Chen, X., Xiang, W., Tang, T. F., & Gan, L. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00620 · Cited by 15

Time Series Analysis Applied to EEG Shows Increased Global Connectivity during Motor Activation Detected in PD Patients Compared to Controls

Maitín, A. M., Perezzan, R., Herráez‐Aguilar, D., Serrano, J. I., del Castillo, M. D., Arroyo-Ferrer, A., Andreo-Jover, J., & Romero, J. P. (2020) · Applied Sciences · doi:10.3390/app11010015 · Cited by 15

Exploring the effects of faecal microbiota transplantation on cognitive function: A review of clinical trials

Alaeddin, S., Chatterjee, A., Roberts, T. L., Steiner-Lim, G. Z., Jensen, S. O., Gyengési, E., Muench, G. W., & Ho, V. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101049 · Cited by 17

Protective effects of 24-epibrassinolide against the 6-OHDA zebrafish model of Parkinson's disease

Gomes, A., Monteiro, S. M., Venâncio, C. A. S., & Félix, L. M. (2023) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2023.109630 · Cited by 14

Dopamine- and Grape-Seed-Extract-Loaded Solid Lipid Nanoparticles: Interaction Studies between Particles and Differentiated SH-SY5Y Neuronal Cell Model of Parkinson’s Disease

Mallamaci, R., Musarò, D., Greco, M., Caponio, A., Castellani, S., Munir, A., Guerra, L., Damato, M., Fracchiolla, G., Coppola, C., et al. (2024) · Molecules · doi:10.3390/molecules29081774 · Cited by 14

Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease–Related Cognitive Impairment

Oh, Y., Kim, J., Lyoo, C. H., Park, G., & Kim, H. (2024) · Neurology · doi:10.1212/wnl.0000000000209498 · Cited by 16

Practical Bayesian Inference in Neuroscience: Or How I Learned to Stop Worrying and Embrace the Distribution

Coventry, B. S., & Bartlett, E. L. (2024) · eNeuro · doi:10.1523/eneuro.0484-23.2024 · Cited by 16

Cell-free amplification of prions: Where do we stand?

Cazzaniga, F. A., Luca, C. M. G. D., Bistaffa, E., Consonni, A., Legname, G., Giaccone, G., & Moda, F. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.005 · Cited by 14

Unexpected Implication of SRP and AGO2 in Parkinson’s Disease: Involvement in Alpha-Synuclein Biogenesis

Hernandez, S. M., Tikhonova, E. B., Baca, K. R., Zhao, F., Zhu, X., & Karamyshev, A. L. (2021) · Cells · doi:10.3390/cells10102792 · Cited by 14

Age-related tolerance to paraquat-induced parkinsonism in Drosophila melanogaster

Neves, P. F. R., Milanesi, B. B., Paz, L. V., Monteiro, V. A. C. D. M., Neves, L. T., da Veiga, L. C., da Silva, R. B., Sulzbach, J. H., Knijkik, G. P., Ribeiro, E. C. D. R., et al. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.03.010 · Cited by 13

Unveiling new secrets in Parkinson’s disease: The glycatome

Chegão, A., & Miranda, H. V. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114309 · Cited by 15

Precision Neurology for Parkinson’s Disease: Coupling Miro1‐Based Diagnosis With Drug Discovery

Bharat, V., & Wang, X. (2020) · Movement Disorders · doi:10.1002/mds.28194 · Cited by 14

The role of microbiota dysbiosis in Parkinson’s disease: Pathophysiology and therapeutic opportunities

Santos, S., Salinas, I., Almeida, N., & Caicedo, A. (2025) · Engineering Microbiology · doi:10.1016/j.engmic.2025.100222 · Cited by 13

Early diagnosis and clinical score prediction of Parkinson's disease based on longitudinal neuroimaging data

Lei, H., Lei, Y., Chen, Z., Li, S., Huang, Z., Zhou, F., Tan, E.-L., Xiao, X., Lei, Y., Hu, H., et al. (2023) · Neural Computing and Applications · doi:10.1007/s00521-023-08508-x · Cited by 13

Midbrain organoids—development and applications in Parkinson’s disease

Toh, H. S. Y., Choo, X. Y., & Sun, A. X. (2023) · Oxford Open Neuroscience · doi:10.1093/oons/kvad009 · Cited by 14

Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson’s Phenotype Development

Karpenko, M. N., Muruzheva, Z. M., Ilyechova, E. Y., Babich, P. S., & Puchkova, L. V. (2023) · Antioxidants · doi:10.3390/antiox12091654 · Cited by 13

Active ingredients of Chinese medicine with immunomodulatory properties: NF-κB pathway and Parkinson's disease

Song, J.-J., Zhao, Y., Shan, X., Luo, Y., Hao, N., & Zhao, L. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148603 · Cited by 14

Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model

García-Gómara, M., Juan-Palencia, A., Alfaro, M., Cuadrado‐Tejedor, M., & García‐Osta, A. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10164-4 · Cited by 13

Association between serum bilirubin concentration and Parkinson's disease: a meta-analysis

Jin, J., Liu, X., Li, M., Bai, X., & Xie, A. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001300 · Cited by 13

Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson’s disease from multiple system atrophy and progressive supranuclear paralysis

Rong, Z., Shen, F., Wang, Y., Sun, L., Wu, J., Zhang, H., Yuan, Y., Jiang, W., Li, X., Ji, P., et al. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135964 · Cited by 13

Cognition, function and awareness of disease impact in early Parkinson’s and Huntington’s disease

Júlio, F., Ribeiro, M. J., Morgadinho, A., Sousa, M., van Asselen, M., Simões, M. R., Castelo-Branco, M. S., & Januário, C. (2020) · Disability and Rehabilitation · doi:10.1080/09638288.2020.1783001 · Cited by 16

Sensitivity of Sniffer Dogs for a Diagnosis of Parkinson's Disease: A Diagnostic Accuracy Study

Gao, C., Wang, S., Wang, M., Li, J., Qiao, J., Huang, J., Zhang, X., Xiang, Y., Xu, Q., Wang, J., et al. (2022) · Movement Disorders · doi:10.1002/mds.29180 · Cited by 13

Transplantation of Stem Cells as a Potential Therapeutic Strategy in Neurodegenerative Disorders

Ebrahimi, T., Abasi, M., Seifar, F., Eyvazi, S., Hejazi, M. S., Tarhriz, V., & Montazersaheb, S. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200628141314 · Cited by 13

Efficacy and safety evaluation of safinamide as an add-on treatment to levodopa for parkinson’s disease

Kurihara, K., Mishima, T., Fujioka, S., & Tsuboi, Y. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.1988926 · Cited by 13

Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioral tests

Gubinelli, F., Cazzolla, G., Negrini, M., Kulacz, I., Mehrdadian, A., Tomasello, G., Venuti, C., Sarauskyte, L., Jacobs, F., Manfredsson, F. P., et al. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113887 · Cited by 14

Monoamine Oxidase Inhibitors in Drug Discovery Against Parkinson’s Disease: An Update

Ribeiro, L. V., Massuda, L. E., Gontijo, V. S., & Viegas, C. (2025) · Pharmaceuticals · doi:10.3390/ph18101526 · Cited by 12

Pathophysiology and Neuroimmune Interactions Underlying Parkinson’s Disease and Traumatic Brain Injury

Lillian, A., Zuo, W., Laham, L., Hilfiker, S., & Ye, J.-H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087186 · Cited by 12

Palmatine Ameliorates Motor Deficits and Dopaminergic Neuron Loss by Regulating NLRP3 Inflammasome through Mitophagy in Parkinson's Disease Model Mice

Zhao, J., Wang, J., Zhao, K., Yang, S., Dong, J., Zhang, Y., Wu, S., Xiang, L., & Hu, W. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04367-2 · Cited by 12

Hippocampal volume is related to olfactory impairment in Parkinson's disease

Roh, H., Kang, J. C., Koh, S., & Kim, J. H. (2021) · Journal of Neuroimaging · doi:10.1111/jon.12911 · Cited by 12

Role of Inflammation in the Development of COVID-19 to Parkinson’s Disease

Liu, T., Wu, H., Sun, L., & Wei, J. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s460161 · Cited by 12

Therapeutic Potential of Baicalein in Parkinson’s Disease: Focus on Inhibition of α-Synuclein Oligomerization and Aggregation

Javed, H., & Ojha, S. K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.83589 · Cited by 12

The Characteristics of Tremor Motion Help Identify Parkinson's Disease and Multiple System Atrophy

Su, D., Yang, S., Hu, W., Wang, D., Kou, W., Liu, Z., Wang, X., Wang, Y., Ma, H., Sui, Y., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00540 · Cited by 12

Behavioral Deficits and Brain α-Synuclein and Phosphorylated Serine-129 α-Synuclein in Male and Female Mice Overexpressing Human α-Synuclein

Gabrielyan, L., Liang, H., Minalyan, A., Hatami, A., John, V., & Wang, L. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200983 · Cited by 12

Cardiovascular, perceived exertion and affective responses during aerobic exercise performed with imposed and a self-selected intensity in patients with Parkinson’s disease

Kanegusuku, H., Correia, M. D. A., Longano, P., Okamoto, E., Piemonte, M. E. P., Cucato, G. G., & Ritti‐Dias, R. M. (2021) · Neurorehabilitation · doi:10.3233/nre-201569 · Cited by 12

Characterization and classification of Parkinson’s disease patients based on symbolic dynamics analysis of heart rate variability

Dorantes-Méndez, G., Méndez, M. O., Méndez-Magdaleno, L. E., Muñoz-Mata, B. G., Rodríguez‐Leyva, I., & Mejia-Rodriguez, A. R. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.103064 · Cited by 11

Multitarget 2′-hydroxychalcones as potential drugs for the treatment of neurodegenerative disorders and their comorbidities

Kamecki, F., Knez, D., Carvalho, D. B., Marcucci, C., Rademacher, M., Higgs, J., Žakelj, S., Marcos, A., Pinto, F. D. T., Abin‐Carriquiry, J. A., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108837 · Cited by 12

A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science

Li, X., Gao, R.-X., Zhang, Q., Li, A., Cai, L., Zhao, W.-W., Gao, S., Wang, Y., & Yue, J. (2022) · Medicine · doi:10.1097/md.0000000000030079 · Cited by 11

Modeling Parkinson’s Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells

Mishima, T., Fujioka, S., Fukae, J., Yuasa‐Kawada, J., & Tsuboi, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123870 · Cited by 12

Effects of possible bisphenol A metabolites on rat spontaneous motor activity

Ishido, M., Masuo, Y., Terasaki, M., Edmonds, J., & Morita, M. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.07.1753

Neuropathology of α‐synuclein in Parkinson's disease

Choong, C., & Mochizuki, H. (2022) · Neuropathology · doi:10.1111/neup.12812 · Cited by 55

Neuropathology of Parkinson's Disease and ParkinsonismPreprint

Dickson, D. W. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041610 · Cited by 16

Neuropathology of Parkinson’s Disease

Jellinger, K. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_2 · Cited by 31

Etiopathogenesis of Parkinson's Disease

Pardasani, V. (2026) · CRC Press eBooks · doi:10.1201/9781003505488-3 · Cited by 1